Retinitis Pigmentosa

Eye implants make vision-restoring progress

(Medical Xpress) -- "I was blind once but now I can see.” The words are no longer the sole property of religious testimony and literature. Medical progress is being made in the restoration of vision as ...

Jul 18, 2012
popularity 4.6 / 5 (10) | comments 4 | with audio podcast report

Steve Wynn: University on path to blindness cure

Las Vegas casino tycoon Steve Wynn said Friday that he gave $25 million to support blindness research at the University of Iowa after becoming convinced that its scientists were leading the way in the search ...

Oct 19, 2013
popularity 4.8 / 5 (66) | comments 11

Engineer invents bionic eye to help the blind

(Medical Xpress)—For UCLA bioengineering professor Wentai Liu, more than two decades of visionary research burst into the headlines last month when the FDA approved what it called "the first bionic eye for the blind." ...

Mar 25, 2013
popularity 5 / 5 (4) | comments 0 | with audio podcast

Retinitis pigmentosa (RP) is a group of genetic eye conditions that leads to incurable blindness. In the progression of symptoms for RP, night blindness generally precedes tunnel vision by years or even decades. Many people with RP do not become legally blind until their 40s or 50s and retain some sight all their lives. Others go completely blind from RP, in some cases as early as childhood. Progression of RP is different in each case.

RP is a type of progressive retinal dystrophy, a group of inherited disorders in which abnormalities of the photoreceptors (rods and cones) or the retinal pigment epithelium (RPE) of the retina lead to progressive visual loss. Affected individuals first experience defective dark adaptation or nyctalopia (night blindness), followed by reduction of the peripheral visual field (known as tunnel vision) and, sometimes, loss of central vision late in the course of the disease.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Building 'smart' cell-based therapies

A Northwestern University synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other ...

Turning off depression in the brain

Scientists have traced vulnerability to depression-like behaviors in mice to out-of-balance electrical activity inside neurons of the brain's reward circuit and experimentally reversed it – but there's ...

Bionic ankle 'emulates nature'

These days, Hugh Herr, an associate professor of media arts and sciences at MIT, gets about 100 emails daily from people across the world interested in his bionic limbs.